Current Portfolio
Egle Therapeutics
Egle is developing a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Treg starving.
Key Facts
- Sector
Life Sciences
- Country
France
- Fund
LSP 7
- Entry
2021
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.